Biomedicines (Oct 2022)

The Value of SIRT1/FOXO1 Signaling Pathway in Early Detection of Cardiovascular Risk in Children with β-Thalassemia Major

  • Hoda A. Ibrahim,
  • Soha S. Zakaria,
  • Manal M. El-Batch,
  • Mohamed R. El-Shanshory,
  • Zahrah R. Alrayes,
  • Ahmed M. Kabel,
  • Samia A. Eldardiry

DOI
https://doi.org/10.3390/biomedicines10102601
Journal volume & issue
Vol. 10, no. 10
p. 2601

Abstract

Read online

Background: Atherosclerosis represents one of the major causes of morbidity in children with β-thalassemia major (β-TM). Aim: This study was designed to investigate SIRT1-FOXO1 signaling in β-TM children and their role in early detection of premature atherosclerosis. Methods: We equally subdivided 100 Egyptian children aged 6–14 years with β-TM according to carotid intima media thickness (CIMT) into 50 with CIMT Results: Our results show significantly high values for CIMT, β-stiffness, atherogenic index of plasma (AIP), MDA, HSP72 and FOXO1, ferritin with significantly low hepcidin, SOD, catalase, and SIRT1 in β-TM as compared to controls with a more significant difference in β-TM with CIMT ≥ 0.5 mm than those with CIMT Conclusion: In β-TM, FOXO1 signaling is activated with low levels of SIRT1, and this is attributed to accelerated atherosclerosis in β-TM, which would be crucial in prediction of atherosclerosis.

Keywords